Dr. Harrison plans to stay in the role of CEO throughout his treatment and will return to the office in 2020.
“Cancer is never good news, of course, but I have every reason to hope for a successful outcome,” Dr. Harrison said in an emailed statement. “I am proud and grateful that my care will be provided by Intermountain caregivers — the best in the land. I look forward to their care and support as I continue to serve our communities as CEO of Intermountain.”
Multiple myeloma is a rare form of cancer in which cancerous plasma cells accumulate in bone marrow. It does not have a cure, but can be managed as a chronic disease, Dr. Harrison noted.
More executive moves:
22 recent hospital, health system executive movesa
IU Health White Memorial Hospital taps Renea Smith as CNO
Sean Lemon named VP of ancillary services for Texas Health Huguley Hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
